March 26, 2022
Oxurion Publishes 2021 Annual Report
Leuven, BELGIUM, Boston, MA, US – March 25, 2022 – 09.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) (the…
Pharmaceuticals, Biotechnology and Life Sciences
Leuven, BELGIUM, Boston, MA, US – March 25, 2022 – 09.00 PM CET – Oxurion NV (Euronext Brussels: OXUR) (the…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) — Histogen Inc. (NASDAQ: HSTO), a clinical-stage company focused on developing potential first-in-class…
SAN FRANCISCO, March 25, 2022 (GLOBE NEWSWIRE) — GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced…
SAN DIEGO, March 25, 2022 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery…
Company Sets New Quarterly Record for Number of Individual E-Commerce Order Transactions New York, NY, March 25, 2022 (GLOBE NEWSWIRE)…
BOSTON, March 25, 2022 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (NASDAQ: RNAZ), a biopharmaceutical company committed to defeating cancer using RNA…
The correction refers to the administrative costs for the period January – December 2021 that due to oversight have been…
PALO ALTO, Calif., March 25, 2022 (GLOBE NEWSWIRE) — Scilex Holding Company (“Scilex”), a majority-owned subsidiary of Sorrento Therapeutics, Inc.…
International Conference on Alzheimer’s and Parkinson’s Diseases Provides New Insights into the Role of Neuroinflammation in AD and the Promise…
Polivy plus R-CHP showed first clinically meaningful improvement in PFS with comparable safety in people with previously untreated diffuse large…